To include your compound in the COVID-19 Resource Center, submit it here.

DNA IL-12: Phase II start

This quarter, OncoSec will begin an open-label, U.S.

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE